Pulmonx entered the week with an updated price target that still signals meaningful upside, even as analysts modestly tweak their assumptions around risk and growth. With fair value steady at $5.75 ...
Roll up, roll up, it’s Deadline’s annual guide to the best TV coming to a small screen near you next year. If you can’t get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback